Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro

Abstract

In recent times, co-delivery of therapeutics has emerged as a promising strategy for treating dreadful diseases such as cancer.Materials and methodsIn this study, we developed a novel nanocarrier based on bacterial magnetosomes (BMs) that co-loaded with siRNA and doxorubicin (DOX) using polyethyleneimine (PEI) as a cross-linker (BMs/DP/siRNA). The delivery efficiency of siRNA as well as the pH-responsive release of DOX, and synergistic efficacy of these therapeutics in vitro were systematically investigated.ResultsThe structure of DOX–PEI (DP) conjugates that synthesized via hydrazone bond formation was confirmed by 1H nuclear magnetic resonance (NMR). The in vitro release experiments showed that the DP conjugate (DOX-loading efficiency – 5.77%±0.08%) exhibited the long-term release behavior. Furthermore, the optimal BMs/DP/siRNA particle size of 107.2 nm and the zeta potential value of 31.1±1.0 mV facilitated enhanced cellular internalization efficiency. Moreover, the agarose gel electrophoresis showed that the co-delivery system could protect siRNA from degradation in serum and RNase A. In addition, the cytotoxicity assay showed that BMs/DP/siRNA could achieve an excellent synergistic effect compared to that of siRNA delivery alone. The acridine orange (AO)/ethidium bromide (EB) double staining assay also showed that BMs/DP/siRNA complex could induce cells in a stage of late apoptosis and nanocomplex located in the proximity of the nucleus.ConclusionThe combination of gene and chemotherapeutic drug using BMs is highly efficient, and the BMs/DP/siRNA would be a promising therapeutic strategy for the future therapeutics.

<p>Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach</p>

“…In addition, MNPs can be coated with siRNAs as well as other chemotherapeutic agents in order to promote delivery to the tumor site by applying external magnetic fields. Some representative examples inducing cellular death by magnetic heating have been reported 150,151…”

Bacterial magnetosomes loaded with doxorubicin and transferrin improve targeted therapy of hepatocellular carcinoma

“…BMs have a uniform particle size (40 - 50 nm), strong magnetism, and a membrane coated with chemical groups such as - NH 2 , - COOH, - OH, which makes them easy to conjugate with antibodies, genes, and drugs. Due to these properties, BMs have become promising candidates for biomedical and biotechnology applications, especially in cancer therapy 25-34. Great progress has been made in the using BMs for applications such as antibody and drug coupling technology 35.…”

Advances in Magnetic Nanoparticles Engineering for Biomedical Applications—A Review

“…Results showed that the Doxorubicin stayed stabile in normal pH blood environment and 40% of the drug was released at a pH-value of 5.5 after 280 h (pH-sensitive drug release). The nanocarrier was also capable to inhibit the proliferation of HeLa cells, and even to induce apoptosis [187].…”